RecruitingNot ApplicableNCT05748015

Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis

Definition of Autonomic Nervous System Involvement in Patients With Relapsing-remitting and Primary Progressive Multiple Sclerosis


Sponsor

Istituti Clinici Scientifici Maugeri SpA

Enrollment

60 participants

Start Date

Mar 4, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this interventional non-pharmacological study is to evaluate the involvement of the autonomic nervous system in patients with relapsing-remitting and primary progressive multiple sclerosis. The main questions it aims to answer are: * Is it possible to define the characteristics of dysautonomia to improve treatment on patients with multiple sclerosis through the management of conditions such as orthostatic hypotension or thermoregulation disorders that inevitably condition the patient's life and the response to rehabilitation ? * Does the severity of the functional alterations correlate with impairment of small somatic and autonomic cutaneous nerve fibers in patients with multiple sclerosis ? * How much the involvement of the autonomic nervous system affects the clinical history and progression of the disease ? * Do different clinical variants of multiple sclerosis manifest with different patterns of involvement of the sensory-autonomic nervous system ? Participants will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment. Patients will perform a sensory and autonomic functional study and a morphological analysis of cutaneous nerves through skin biopsy. Researchers will compare results between the two groups (relapsing-remitting and primary progressive) and between patients and data from control subjects.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how multiple sclerosis (MS) affects the autonomic nervous system — the part of the nervous system that controls automatic body functions like heart rate, blood pressure, digestion, and bladder function. Researchers hope to better understand and treat these often-overlooked symptoms. **You may be eligible if...** - You have been diagnosed with relapsing-remitting multiple sclerosis OR primary progressive multiple sclerosis **You may NOT be eligible if...** - You have another neurological condition - You are taking medications known to be potentially toxic to the nervous system - You have another form of MS not listed above Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTquantification of sensory and autonomic small nerve fibers by punch skin biopsy

We'll perform a punch skin biopsy of 3mm from thigh, leg and fingertip and we'll quantify peripheral sensory and autonomic nerve fibers.

DIAGNOSTIC_TESTCardiovascular Reflexes testing

Cardiovascular reflex tests including deep breathing, head-up Tilt, standing, isometric exercises, mental arithmetic and Valsalva maneuver.

OTHERAdministration of clinical scales evaluating autonomic symptoms, pain small fiber neuropathy symptoms

We'll characterize patients' symptoms through the administration of clinical scales such as: COMPASS 31 autonomic symptoms scale; Small Fiber Neuropathy Symptom Inventory Questionnaire (SFN-SIQ), the Pain Detect Questionnaire and the Total neuropathy score


Locations(2)

ICS Maugeri - IRCCS of Telese Terme

Telese Terme, Benevento, Italy

Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II

Naples, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05748015


Related Trials